{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:51:17Z","timestamp":1788817877896,"version":"build-2803163510"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p> There is evidence that iron affects lipid metabolism and adipocyte biology. Given the effects of iron on adiponectin, the role of iron in lipid oxidation, and the potential additive effects of oxidative stress from excess iron and lipid metabolism. We aimed to investigate serum adiponectin in relation to clinical and laboratory parameters including the inflammation markers [C-reacitve protein (CRP) and interleukin-6 (IL-6)] in \u03b2-thalassaemia major children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p> We investigated 58 \u03b2-thalassaemia major children under scheduled blood transfusion and 30 controls. Routine clinical evaluation, laboratory investigations including serum ferritin as well as CRP measured by immunoturbidimetry, IL-6 and serum adiponectin measured by ELISA are performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p> CRP, IL-6 and serum adiponectin levels were higher in patients than controls (p&lt;0.001, p=0.04 and p&lt;0.001, respectively). Patients received desferoxamine showed significantly lower levels of adiponectin than those did not receive it (mean\u00b1SD=4.50\u00b13.37 vs. 9.96\u00b19.68, p=0.006). Serum adiponectin was significantly negatively correlated with hemoglobin (Hb) concentration (r=\u20130.36, p=0.005). It was significantly positively correlated with platelets count, serum ferritin, CRP and IL-6 (r=0.27, r=0.26, r=0.30, r=0.35, respectively and p=0.04, p=0.04, p=0.01, p=0.008, respectively). Serum ferritin and IL-6 were the significant predictors of serum adiponectin level (p&lt;0.001 and p=0.003, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p> Serum adiponectin was increased in \u03b2-thalassaemia major as were pro-inflammatory markers (CRP and IL-6). Its level is directly associated with ferritin and IL-6 levels.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2016-0014","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T10:01:26Z","timestamp":1464429686000},"page":"953-958","source":"Crossref","is-referenced-by-count":11,"title":["Elevated serum adiponectin is related to elevated serum ferritin and interleukin-6 in \u03b2-thalassaemia major children"],"prefix":"10.1515","volume":"29","author":[{"given":"Farida H.","family":"El-Rasheidy","sequence":"first","affiliation":[{"name":"Department of Paediatrics , Faculty of Medicine, Menoufia University , Shebein ElKom, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas S.","family":"Essa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology , Faculty of Medicine, Menoufia University , Shebein ElKom, Menoufia, Egypt, Phone: 002\/01006795544, Fax: 002\/0482223964"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa A.S.","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , Faculty of Medicine, Menoufia University , Shebein ElKom, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd El-wahab A.A.","family":"Nada","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , Faculty of Medicine, Menoufia University , Shebein ElKom, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2016,5,28]]},"reference":[{"key":"2023040100561073661_j_jpem-2016-0014_ref_001_w2aab2b8c41b1b7b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Aggeli C, Antoniades C, Cosma C, Chrysohoou C, Tousoulis D, et al. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol 2005;105:80\u20134.","DOI":"10.1016\/j.ijcard.2004.12.025"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_002_w2aab2b8c41b1b7b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Kanavaki I, Makrythanasis P, Lazaropoulou C, Tsironi M, Kattamis A, et al. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia. Blood Cells Mol Dis 2009;43:230\u20134.","DOI":"10.1016\/j.bcmd.2009.06.002"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_003_w2aab2b8c41b1b7b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004;35:842\u20139.","DOI":"10.1016\/j.bone.2004.06.008"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_004_w2aab2b8c41b1b7b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Ehling A, Schaffler A, Herfarth H, Tarner IH, Anders S, et al. The potential of adiponectin in driving arthritis. J Immunol 2006;176:4468\u201378.","DOI":"10.4049\/jimmunol.176.7.4468"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_005_w2aab2b8c41b1b7b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 2004;145:5589\u201397.","DOI":"10.1210\/en.2004-0503"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_006_w2aab2b8c41b1b7b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007;380:24\u201330.","DOI":"10.1016\/j.cca.2007.01.026"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_007_w2aab2b8c41b1b7b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Stakos DA, Papaioannou HI, Angelidou I, Mantadakis E, Paraskakis E, et al. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children. J Pediatr Endocrinol Metab 2014;27:221\u20138.","DOI":"10.1515\/jpem-2013-0195"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_008_w2aab2b8c41b1b7b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 2007;132:601\u201314.","DOI":"10.1053\/j.gastro.2006.11.026"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_009_w2aab2b8c41b1b7b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Tsatsanis C, Zacharioudaki V, Androulidaki A, Dermitzaki E, Charalampopoulos I, et al. Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann NY Acad Sci 2006;1083:185\u201395.","DOI":"10.1196\/annals.1367.013"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_010_w2aab2b8c41b1b7b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Otero M, Lago R, Gomez R, Lago F, Dieguez C, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1198\u2013201.","DOI":"10.1136\/ard.2005.046540"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_011_w2aab2b8c41b1b7b1ab2b1c11Aa","unstructured":"Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 2006;33:1545\u201352."},{"key":"2023040100561073661_j_jpem-2016-0014_ref_012_w2aab2b8c41b1b7b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Yamamoto K, Kiyohara T, Murayama Y, Kihara S, Okamoto Y, et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn\u2019s disease. Gut 2005;54:789\u201396.","DOI":"10.1136\/gut.2004.046516"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_013_w2aab2b8c41b1b7b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992;11:1305\u201319.","DOI":"10.1002\/sim.4780111005"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_014_w2aab2b8c41b1b7b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Chaliasos N, Challa A, Hatzimichael E, Koutsouka F, Bourantas DK, et al. Serum adipocytokine and vascular inflammation marker levels in beta-thalassaemia major patients. Acta Haematol 2010;124:191\u20136.","DOI":"10.1159\/000320274"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_015_w2aab2b8c41b1b7b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Ehteram H, Bavarsad MS, Mokhtari M, Saki N, Soleimani M, et al. Prooxidant-antioxidant balance and hs-CRP in patients with beta-thalassemia major. Clin Lab 2014;60:207\u201315.","DOI":"10.7754\/Clin.Lab.2013.130132"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_016_w2aab2b8c41b1b7b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Elsayh KI, Mohammed WS, Zahran AM, Saad K. Leukocytes apoptosis and adipocytokines in children with beta thalassemia major. Clin Exp Med 2015. [Epub ahead of print].","DOI":"10.1007\/s10238-015-0361-6"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_017_w2aab2b8c41b1b7b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Morabito N, Russo GT, Gaudio A, Lasco A, Catalano A, et al. The \u201clively\u201d cytokines network in beta-thalassemia major-related osteoporosis. Bone 2007;40:1588\u201394.","DOI":"10.1016\/j.bone.2007.02.020"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_018_w2aab2b8c41b1b7b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Enli Y, Balci YI, G\u00f6nen C, Uzun E, Polat A. Adipocytokine concentrations in children with different types of beta-thalassemia. Scand J Clin Lab Invest 2014;74:306\u201311.","DOI":"10.3109\/00365513.2014.883639"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_019_w2aab2b8c41b1b7b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Tsatsanis C, Zacharioudaki V, Androulidaki A, Dermitzaki E, Charalampopoulos I, et al. Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun 2005;335:1254\u201363.","DOI":"10.1016\/j.bbrc.2005.07.197"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_020_w2aab2b8c41b1b7b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Pajvani UB, Du X, Combs TP, Barg AH, Rajala MW, et al. Structure-function studies of the adipocyte-secreted hormone ACRP30\/adiponectin. J Biol Chem 2003;278: 9073\u201385.","DOI":"10.1074\/jbc.M207198200"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_021_w2aab2b8c41b1b7b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. J Biol Chem 2003;278:40352\u201363.","DOI":"10.1074\/jbc.M300365200"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_022_w2aab2b8c41b1b7b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004;94:e27\u201331.","DOI":"10.1161\/01.RES.0000119921.86460.37"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_023_w2aab2b8c41b1b7b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Kattamis C, Kattamis AC. Oxidative stress disturbances in erythrocytes of beta-thalassemia. Pediatr Hematol Oncol 2001;18:85\u20138.","DOI":"10.1080\/088800101300002900"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_024_w2aab2b8c41b1b7b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006;135:254\u201363.","DOI":"10.1111\/j.1365-2141.2006.06277.x"},{"key":"2023040100561073661_j_jpem-2016-0014_ref_025_w2aab2b8c41b1b7b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab 2013;17:329\u201341.","DOI":"10.1016\/j.cmet.2013.02.007"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0014\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0014\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T17:17:26Z","timestamp":1680369446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0014\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,28]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,5,16]]},"published-print":{"date-parts":[[2016,8,1]]}},"alternative-id":["10.1515\/jpem-2016-0014"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2016-0014","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,28]]}}}